ARCHIVES

Banned Investigator Plans To Resume Clinical Trials Role

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

PCORI Approves $54.8 Million For Clinical Effectiveness Research

August 1, 2014

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

In Brief: House Hearings On NIH Budget Begin Feb. 1; Army Program Is Peer Reviewing Proposals

January 28, 1994

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

Duke Scores Highest On NCAB Review

July 14, 1978